| Product Code: ETC7222556 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 France Lumasiran Market Overview |
3.1 France Country Macro Economic Indicators |
3.2 France Lumasiran Market Revenues & Volume, 2021 & 2031F |
3.3 France Lumasiran Market - Industry Life Cycle |
3.4 France Lumasiran Market - Porter's Five Forces |
3.5 France Lumasiran Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 France Lumasiran Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 France Lumasiran Market Revenues & Volume Share, By Dosage form, 2021 & 2031F |
3.8 France Lumasiran Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 France Lumasiran Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.10 France Lumasiran Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 France Lumasiran Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of rare diseases such as primary hyperoxaluria type 1 (PH1) in France |
4.2.2 Growing investment in healthcare infrastructure and research and development activities |
4.2.3 Rising adoption of advanced therapies for genetic disorders in the French healthcare system |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements and approval processes for new drug therapies in France |
4.3.2 Limited awareness and understanding of RNA interference (RNAi) technology among healthcare professionals and patients in France |
5 France Lumasiran Market Trends |
6 France Lumasiran Market, By Types |
6.1 France Lumasiran Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 France Lumasiran Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 France Lumasiran Market Revenues & Volume, By Miscellaneous Metabolic Agents, 2021- 2031F |
6.1.4 France Lumasiran Market Revenues & Volume, By others, 2021- 2031F |
6.2 France Lumasiran Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 France Lumasiran Market Revenues & Volume, By Primary Hyperoxaluria, 2021- 2031F |
6.2.3 France Lumasiran Market Revenues & Volume, By Others, 2021- 2031F |
6.3 France Lumasiran Market, By Dosage form |
6.3.1 Overview and Analysis |
6.3.2 France Lumasiran Market Revenues & Volume, By Injection, 2021- 2031F |
6.3.3 France Lumasiran Market Revenues & Volume, By Solution, 2021- 2031F |
6.4 France Lumasiran Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 France Lumasiran Market Revenues & Volume, By Subcutaneous, 2021- 2031F |
6.4.3 France Lumasiran Market Revenues & Volume, By Demographic, 2021- 2031F |
6.4.4 France Lumasiran Market Revenues & Volume, By Adult, 2021- 2031F |
6.4.5 France Lumasiran Market Revenues & Volume, By Pediatric, 2021- 2031F |
6.5 France Lumasiran Market, By End-Users |
6.5.1 Overview and Analysis |
6.5.2 France Lumasiran Market Revenues & Volume, By Clinics, 2021- 2031F |
6.5.3 France Lumasiran Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.4 France Lumasiran Market Revenues & Volume, By Diagnostic center, 2021- 2031F |
6.6 France Lumasiran Market, By Distribution Channel |
6.6.1 Overview and Analysis |
6.6.2 France Lumasiran Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.6.3 France Lumasiran Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.6.4 France Lumasiran Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
7 France Lumasiran Market Import-Export Trade Statistics |
7.1 France Lumasiran Market Export to Major Countries |
7.2 France Lumasiran Market Imports from Major Countries |
8 France Lumasiran Market Key Performance Indicators |
8.1 Patient enrollment in clinical trials for lumasiran in France |
8.2 Number of healthcare facilities offering lumasiran therapy in key regions of France |
8.3 Patient adherence and compliance rates to lumasiran treatment regimen |
8.4 Number of publications and research studies on lumasiran conducted by French researchers |
8.5 Level of reimbursement coverage and access to lumasiran therapy for patients in France |
9 France Lumasiran Market - Opportunity Assessment |
9.1 France Lumasiran Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 France Lumasiran Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 France Lumasiran Market Opportunity Assessment, By Dosage form, 2021 & 2031F |
9.4 France Lumasiran Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.5 France Lumasiran Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.6 France Lumasiran Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 France Lumasiran Market - Competitive Landscape |
10.1 France Lumasiran Market Revenue Share, By Companies, 2024 |
10.2 France Lumasiran Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here